BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kar R, Jha NK, Jha SK, Sharma A, Dholpuria S, Asthana N, Chaurasiya K, Singh VK, Burgee S, Nand P. A "NOTCH" Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer. Genes (Basel) 2019;10:E961. [PMID: 31766724 DOI: 10.3390/genes10120961] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Pouliquen DL, Boissard A, Henry C, Coqueret O, Guette C. Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies. Front Pharmacol 2022;13:934534. [DOI: 10.3389/fphar.2022.934534] [Reference Citation Analysis]
2 Sukumar DT, Gunasangkaran G, Arumugam VA, Muthukrishnan S. Effects of biogenic synthesis of chitosan entrapped silver nanoparticle from Aegle marmelos on human cervical cancer cells (HeLa). Journal of Drug Delivery Science and Technology 2022;70:103189. [DOI: 10.1016/j.jddst.2022.103189] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ge H, Xu C, Chen H, Liu L, Zhang L, Wu C, Lu Y, Yao Q. Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms. Front Pharmacol 2022;13:842295. [DOI: 10.3389/fphar.2022.842295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Imodoye SO, Adedokun KA, Muhammed AO, Bello IO, Muhibi MA, Oduola T, Oyenike MA. Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight Into the Roles of Transcription Factors. Front Oncol 2021;11:762817. [PMID: 34868979 DOI: 10.3389/fonc.2021.762817] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Czerwiński M, Bednarska-Czerwińska A, Ordon P, Gradzik M, Oplawski M, Boroń D, Zientek H, Ogloszka O, Grabarek BO. Variances in the Expression of mRNAs and miRNAs Related to the Histaminergic System in Endometrioid Endometrial Cancer. Biomedicines 2021;9:1535. [PMID: 34829764 DOI: 10.3390/biomedicines9111535] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Chong ZX, Yeap SK, Ho WY. Unraveling the roles of miRNAs in regulating epithelial-to-mesenchymal transition (EMT) in osteosarcoma. Pharmacol Res 2021;172:105818. [PMID: 34400316 DOI: 10.1016/j.phrs.2021.105818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sisto M, Ribatti D, Lisi S. ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving Story and Its Link to Fibrosis and Cancer. J Clin Med 2021;10:3373. [PMID: 34362154 DOI: 10.3390/jcm10153373] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Wawruszak A, Halasa M, Okon E, Kukula-Koch W, Stepulak A. Valproic Acid and Breast Cancer: State of the Art in 2021. Cancers (Basel) 2021;13:3409. [PMID: 34298623 DOI: 10.3390/cancers13143409] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
9 Wang H, Song X, Liao H, Wang P, Zhang Y, Che L, Zhang J, Zhou Y, Cigliano A, Ament C, Superville D, Ribback S, Reeves M, Pes GM, Liang B, Wu H, Evert M, Calvisi DF, Zeng Y, Chen X. Overexpression of Mothers Against Decapentaplegic Homolog 7 Activates the Yes-Associated Protein/NOTCH Cascade and Promotes Liver Carcinogenesis in Mice and Humans. Hepatology 2021;74:248-63. [PMID: 33368437 DOI: 10.1002/hep.31692] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
10 Cai Y, Wang B, Li B, Huang X, Guo H, Liu Y, Chen B, Zhao S, Wu S, Li W, Wang L, Jia K, Wang H, Chen P, Jiang M, Tang X, Qi H, Dai C, Ye J, He Y. Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review. Ann Transl Med 2021;9:946. [PMID: 34350261 DOI: 10.21037/atm-20-7002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Du T, Wang D, Wan X, Xu J, Xiao Q, Liu B. Regulatory effect of microRNA-223-3p on breast cancer cell processes via the Hippo/Yap signaling pathway. Oncol Lett 2021;22:516. [PMID: 33986876 DOI: 10.3892/ol.2021.12777] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
12 Tian X, Wu L, Jiang M, Zhang Z, Wu R, Miao J, Liu C, Gao S. Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer. Front Oncol 2021;11:641399. [PMID: 33968740 DOI: 10.3389/fonc.2021.641399] [Reference Citation Analysis]
13 Rybinska I, Mangano N, Tagliabue E, Triulzi T. Cancer-Associated Adipocytes in Breast Cancer: Causes and Consequences. Int J Mol Sci 2021;22:3775. [PMID: 33917351 DOI: 10.3390/ijms22073775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Opławski M, Nowakowski R, Średnicka A, Ochnik D, Grabarek BO, Boroń D. Molecular Landscape of the Epithelial-Mesenchymal Transition in Endometrioid Endometrial Cancer. J Clin Med 2021;10:1520. [PMID: 33917330 DOI: 10.3390/jcm10071520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kar R, Jha SK, Ojha S, Sharma A, Dholpuria S, Raju VSR, Prasher P, Chellappan DK, Gupta G, Kumar Singh S, Paudel KR, Hansbro PM, Kumar Singh S, Ruokolainen J, Kesari KK, Dua K, Jha NK. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues. Cancer Rep (Hoboken) 2021;4:e1369. [PMID: 33822486 DOI: 10.1002/cnr2.1369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
16 Akil A, Gutiérrez-García AK, Guenter R, Rose JB, Beck AW, Chen H, Ren B. Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective. Front Cell Dev Biol 2021;9:642352. [PMID: 33681228 DOI: 10.3389/fcell.2021.642352] [Cited by in Crossref: 5] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
17 Ming H, Li B, Zhou L, Goel A, Huang C. Long non-coding RNAs and cancer metastasis: Molecular basis and therapeutic implications. Biochim Biophys Acta Rev Cancer 2021;1875:188519. [PMID: 33548345 DOI: 10.1016/j.bbcan.2021.188519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
18 Petri BJ, Klinge CM. Regulation of breast cancer metastasis signaling by miRNAs. Cancer Metastasis Rev 2020;39:837-86. [PMID: 32577859 DOI: 10.1007/s10555-020-09905-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
19 Borlak F, Reutzel-Selke A, Schirmeier A, Gogolok J, von Hoerschelmann E, Sauer IM, Pratschke J, Bahra M, Schmuck RB. Notch Signaling Pathway in Pancreatobiliary Tumors. Medicina (Kaunas) 2021;57:105. [PMID: 33498866 DOI: 10.3390/medicina57020105] [Reference Citation Analysis]
20 Orzechowska M, Anusewicz D, Bednarek AK. Functional Gene Expression Differentiation of the Notch Signaling Pathway in Female Reproductive Tract Tissues-A Comprehensive Review With Analysis. Front Cell Dev Biol 2020;8:592616. [PMID: 33384996 DOI: 10.3389/fcell.2020.592616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bao C, Liu T, Qian L, Xiao C, Zhou X, Ai H, Wang J, Fan W, Pan J. Shikonin inhibits migration and invasion of triple-negative breast cancer cells by suppressing epithelial-mesenchymal transition via miR-17-5p/PTEN/Akt pathway. J Cancer 2021;12:76-88. [PMID: 33391404 DOI: 10.7150/jca.47553] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
22 Huang C, Chen J. Laminin‑332 mediates proliferation, apoptosis, invasion, migration and epithelial‑to‑mesenchymal transition in pancreatic ductal adenocarcinoma. Mol Med Rep 2021;23:11. [PMID: 33179081 DOI: 10.3892/mmr.2020.11649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
23 Brindisi M, Fiorillo M, Frattaruolo L, Sotgia F, Lisanti MP, Cappello AR. Cholesterol and Mevalonate: Two Metabolites Involved in Breast Cancer Progression and Drug Resistance through the ERRα Pathway. Cells 2020;9:E1819. [PMID: 32751976 DOI: 10.3390/cells9081819] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
24 Ashrafizadeh M, Ang HL, Moghadam ER, Mohammadi S, Zarrin V, Hushmandi K, Samarghandian S, Zarrabi A, Najafi M, Mohammadinejad R, Kumar AP. MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy. Biomolecules 2020;10:E1040. [PMID: 32664703 DOI: 10.3390/biom10071040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
25 Khan F, Pandey P, Ahmad V, Upadhyay TK. Moringa oleifera methanolic leaves extract induces apoptosis and G0/G1 cell cycle arrest via downregulation of Hedgehog Signaling Pathway in human prostate PC-3 cancer cells. J Food Biochem 2020;44:e13338. [PMID: 32588472 DOI: 10.1111/jfbc.13338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
26 Moore G, Annett S, McClements L, Robson T. Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives. Cells 2020;9:E1503. [PMID: 32575680 DOI: 10.3390/cells9061503] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 28.0] [Reference Citation Analysis]
27 Ashrafizadeh M, Zarrabi A, Samarghandian S, Najafi M. PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer? Eur J Pharmacol 2020;881:173226. [PMID: 32485246 DOI: 10.1016/j.ejphar.2020.173226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
28 Tam SY, Wu VWC, Law HKW. Hypoxia-Induced Epithelial-Mesenchymal Transition in Cancers: HIF-1α and Beyond. Front Oncol 2020;10:486. [PMID: 32322559 DOI: 10.3389/fonc.2020.00486] [Cited by in Crossref: 34] [Cited by in F6Publishing: 72] [Article Influence: 17.0] [Reference Citation Analysis]
29 Testa U, Castelli G, Pelosi E. Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments. Med Sci (Basel) 2020;8:E18. [PMID: 32210163 DOI: 10.3390/medsci8010018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
30 Seyfried TN, Mukherjee P, Iyikesici MS, Slocum A, Kalamian M, Spinosa JP, Chinopoulos C. Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer. Front Nutr 2020;7:21. [PMID: 32219096 DOI: 10.3389/fnut.2020.00021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]